High prevalence of heteroresistance in Staphylococcus aureus is caused by a multitude of mutations in core genes

PLoS Biol. 2024 Jan 4;22(1):e3002457. doi: 10.1371/journal.pbio.3002457. eCollection 2024 Jan.

Abstract

Heteroresistance (HR) is an enigmatic phenotype where, in a main population of susceptible cells, small subpopulations of resistant cells exist. This is a cause for concern, as this small subpopulation is difficult to detect by standard antibiotic susceptibility tests, and upon antibiotic exposure the resistant subpopulation may increase in frequency and potentially lead to treatment complications or failure. Here, we determined the prevalence and mechanisms of HR for 40 clinical Staphylococcus aureus isolates, against 6 clinically important antibiotics: daptomycin, gentamicin, linezolid, oxacillin, teicoplanin, and vancomycin. High frequencies of HR were observed for gentamicin (69.2%), oxacillin (27%), daptomycin (25.6%), and teicoplanin (15.4%) while none of the isolates showed HR toward linezolid or vancomycin. Point mutations in various chromosomal core genes, including those involved in membrane and peptidoglycan/teichoic acid biosynthesis and transport, tRNA charging, menaquinone and chorismite biosynthesis and cyclic-di-AMP biosynthesis, were the mechanisms responsible for generating the resistant subpopulations. This finding is in contrast to gram-negative bacteria, where increased copy number of bona fide resistance genes via tandem gene amplification is the most prevalent mechanism. This difference can be explained by the observation that S. aureus has a low content of resistance genes and absence of the repeat sequences that allow tandem gene amplification of these genes as compared to gram-negative species.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Daptomycin*
  • Gentamicins
  • Humans
  • Linezolid / therapeutic use
  • Mutation
  • Oxacillin / therapeutic use
  • Prevalence
  • Staphylococcal Infections* / drug therapy
  • Staphylococcal Infections* / genetics
  • Staphylococcus aureus / genetics
  • Teicoplanin / therapeutic use
  • Vancomycin

Substances

  • Vancomycin
  • Daptomycin
  • Linezolid
  • Teicoplanin
  • Anti-Bacterial Agents
  • Oxacillin
  • Gentamicins